Indonesia Pharmaceutical Market Dynamics
Indonesia Pharmaceutical Market Dynamics
$2,995.00
Kalbe Farma is the leading player by some margin, with a market share of 13% in 2011, while GlaxoSmithKline is the largest foreign player with a 3% share.
Publisher: Datamonitor Healthcare
- Description
- Contents
- Samples
Kalbe Farma is the leading player by some margin, with a market share of 13% in 2011, while GlaxoSmithKline is the largest foreign player with a 3% share.
Indonesia’s rapid economic growth will be the biggest market driver, while a growing and aging population is also a long-term driver.
Table of Contents
4 EXECUTIVE SUMMARY
4 Key findings
5 MARKET SIZE
5 Generics
6 OTCs
6 Vaccines
7 DRIVERS/RESISTORS OF GROWTH
8 CORPORATE ENVIRONMENT
9 Corporate highlights – foreign multinationals
10 Corporate highlights – domestic companies
14 BIBLIOGRAPHY
List of Figures
5 Figure 1: Indonesia: Pharmaceutical sales ($bn), 2006–11
8 Figure 2: Market share of top seven pharmaceutical companies ($m), 2011
11 Figure 3: Kimia Farma: sales by business sector, H1 2012
Figure 1: Indonesia: Pharmaceutical sales ($bn), 2006–11
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Germany Generics and Biosimilars 
Sign up to the